You can calculate your total cholesterol — including LDL, HDL, and triglycerides — with a blood test, so your doctor can ...

You can lower triglycerides with weight loss and exercise, and if your levels are really high, your doctor may also recommend ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline results from the pivotal Phase 3 CORE and CORE2 studies of olezarsen in people with severe hypertriglyceridemia (sHTG). In ...

The Board of Directors of CSPC Pharmaceutical Group recently announced that its novel SYH2070 siRNA injection received regulatory approval to begin clinical trials in both the U.S. and China for the ...

Clin Lipidology. 2009;4(4):425-437. Clinical event trials are urgently needed to assess treatment strategies for dyslipidemia management, including POM3 treatment, in patients with ...

Our RNAi play came from the understanding that personalization and the development of curated therapies are the future of ...

Biopharmaceutical Amarin Corp. plc today is reporting positive, statistically significant top-line results from its first Phase 3 clinical trial of lead drug candidate AMR101, which is being ...

Amarin Corp., an Irish biopharmaceutical with U.S. operations in Mystic, Conn., said today that its drug candidate AMR101 showed significant decreases in triglycerides during a Phase 3 trial. Amarin ...

Detailed price information for Ionis Pharmaceuticals (IONS-Q) from The Globe and Mail including charting and trades.

The last time I spoke about 89bio, Inc. (NASDAQ:ETNB) it was regarding a Seeking Alpha article entitled “89bio: Bullish In Light Of Further MOA Being Established By Peer.” In this article, I noted the ...